Health and Fitness Health and Fitness
Wed, October 31, 2012
Tue, October 30, 2012
Mon, October 29, 2012

BIOLASE to Discuss Third Quarter 2012 Financial Results on November 5, 2012 Conference Call


Published on 2012-10-29 13:16:49 - Market Wire
  Print publication without navigation


October 29, 2012 16:00 ET

BIOLASE to Discuss Third Quarter 2012 Financial Results on November 5, 2012 Conference Call

IRVINE, CA--(Marketwire - Oct 29, 2012) - [ BIOLASE, Inc ]. (NASDAQ: [ BIOL ]), the World's leading biological dental laser manufacturer and distributor, today announced that the Company will host a conference call on Monday, November 5th, at 4:30 p.m. Eastern Standard Time to discuss its operating results for the third quarter and nine months ended September 30, 2012, and to answer questions. A press release disclosing the Company's financial results will be distributed at approximately 4:05 p.m. Eastern Time that same day.

Phone Participation
To listen to the conference call live via telephone, dial 1-877-941-4775 from the U.S. or, for international callers, dial 1-480-629-9761, approximately 10 minutes before the start time.

Webcast Participation
To listen to the conference call live via the Internet, visit the Investors section of the BIOLASE website at [ www.biolase.com ].

Replay
An audio archive of the webcast will be available for 30 days on the Investors section of the BIOLASE website.

About BIOLASE, Inc.
BIOLASE, Inc., the world's leading Dental Laser Company, is a medical technology company that develops, manufactures and markets [ dental lasers ] and also distributes and markets dental [ imaging equipment ]; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate approximately 290 patented and patent pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 20,100 lasers among 16,000 customers. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on laser and WaterLase™ dentistry, find BIOLASE at [ www.biolase.com ], Facebook at [ www.facebook.com/biolaseinc ], Twitter at [ www.twitter.com/biolaseinc ], and YouTube at [ www.youtube.com/biolasevideos ].

WaterLase™ is a trademark of BIOLASE, Inc.


Contributing Sources